Indaptus Therapeutics Inc (INDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,729 | -28,909 | -18,857 | -11,205 | -4,684 |
| Depreciation Amortization | 206 | 829 | 613 | 400 | 198 |
| Other Working Capital | -488 | 5,090 | 2,424 | 2,074 | 271 |
| Other Operating Activity | 756 | 858 | 860 | 203 | 19 |
| Operating Cash Flow | $-10,255 | $-22,132 | $-14,960 | $-8,528 | $-4,196 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 46 | 247 | 254 | 219 | 179 |
| PPE Investments | -2,022 | -4,994 | -2,440 | -1,629 | -325 |
| Investing Cash Flow | $-1,976 | $-4,747 | $-2,186 | $-1,410 | $-146 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 63,707 | 63,681 | 9,525 | 9,525 |
| Financing Cash Flow | $N/A | $63,707 | $63,681 | $9,525 | $9,525 |
| Exchange Rate Effect | 40 | 127 | 66 | 99 | 28 |
| Beginning Cash Position | 53,393 | 16,438 | 16,376 | 16,376 | 16,376 |
| End Cash Position | 41,202 | 53,393 | 62,977 | 16,062 | 21,587 |
| Net Cash Flow | $-12,191 | $36,955 | $46,601 | $-314 | $5,211 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,255 | -22,132 | -14,960 | -8,528 | -4,196 |
| Capital Expenditure | -2,022 | -5,001 | -2,447 | -1,636 | -332 |
| Free Cash Flow | -12,277 | -27,133 | -17,407 | -10,164 | -4,528 |